Sir Keir Starmer and his health secretary have been lauding the potential of the new generation of weight-loss drugs. Given as regular injections, the treatments – Wegovy and Mounjaro – mimic a hormone that makes people less hungry.

New weight loss jabs could be given to unemployed people to help them get back into work, Sir Keir Starmer has said. The Prime Minister said that the drugs would be “very important” for reducing obesity rates and helping to reduce the burden on the NHS.

All the evidence gathered from the five-year trial will be used to demonstrate the long-term effect of weight loss medication. Those behind the study say the results could help develop the care pathways set by health services for treating people with obesity.

WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its weight-management programs, sending its shares up 13% in early trading. Soaring demand for weight-loss drugs such as Wegovy and Eli Lilly's Zepbound,

As with any new drug, parents and doctors may worry that the use of GLP-1 weight-loss meds by children and teens might raise psychiatric risks, including the risk for suicide and suicidal thoughts. But a new study involving more than 54,

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.